Floatz logo

Interleukin 7

B-Cell Non-Hodgkin Lymphoma

Wenbin Qianprotein_peptidePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

306 Active assets in the B-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Vindesine
Children's Cancer Group, China
Phase 4BBB
Anti-Cd20/Cd3 Monoclonal Antibody Regn1979
University of Birmingham
Phase 3BBB
Cytarabine
Children's Cancer Group, China
Phase 4BBB
Methotrexate
Children's Cancer Group, China
Phase 4BBB
Camustine
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB

View all 50 →

Same molecule, other indications

Interleukin 7 is also rated in:

breast cancerDormant
CCC
Indicative · Phase 2
54 / 100
View asset →
embryonal rhabdomyosarcomaDormant
CCC
Indicative · Phase 1/2
52 / 100
View asset →
alveolar rhabdomyosarcomaDormant
CCC
Indicative · Phase 1/2
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →